An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
Condition(s):Ulcerative ColitisLast Updated:March 15, 2024Recruiting